共 50 条
- [1] Venetoclax for the treatment of newly diagnosed acute myeloid leukemia in patients who are ineligible for intensive chemotherapyTHERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10Richard-Carpentier, Guillaume论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd,Box 428, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd,Box 428, Houston, TX 77030 USADiNardo, Courtney D.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd,Box 428, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd,Box 428, Houston, TX 77030 USA
- [2] Cusatuzumab plus azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia ineligible for intensive treatmentCANCER SCIENCE, 2023, 114 (03) : 1037 - 1044Ikezoe, Takayuki论文数: 0 引用数: 0 h-index: 0机构: Fukushima Med Univ, Dept Hematol, Fukushima, Japan Fukushima Med Univ, Dept Hematol, Fukushima, JapanUsuki, Kensuke论文数: 0 引用数: 0 h-index: 0机构: NTT Med Ctr, Dept Hematol, Tokyo, Japan Fukushima Med Univ, Dept Hematol, Fukushima, JapanAida, Kensuke论文数: 0 引用数: 0 h-index: 0机构: Janssen Pharmaceut KK, Tokyo, Japan Fukushima Med Univ, Dept Hematol, Fukushima, JapanHatayama, Tomoyoshi论文数: 0 引用数: 0 h-index: 0机构: Janssen Pharmaceut KK, Tokyo, Japan Fukushima Med Univ, Dept Hematol, Fukushima, JapanShirahase, Toru论文数: 0 引用数: 0 h-index: 0机构: Janssen Pharmaceut KK, Tokyo, Japan Fukushima Med Univ, Dept Hematol, Fukushima, Japan论文数: 引用数: h-index:机构:
- [3] HEALTH STATE UTILITIES FOR PATIENTS WITH ACUTE MYELOID LEUKEMIA WHO ARE INELIGIBLE FOR INTENSIVE CHEMOTHERAPYVALUE IN HEALTH, 2022, 25 (01) : S230 - S230Pratz, K.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Penn, Philadelphia, PA USA Hosp Univ Penn, Philadelphia, PA USALachaine, J.论文数: 0 引用数: 0 h-index: 0机构: PeriPharm, Montreal, PQ, Canada Hosp Univ Penn, Philadelphia, PA USASuh, H. S.论文数: 0 引用数: 0 h-index: 0机构: Kyung Hee Univ, Seoul, South Korea Hosp Univ Penn, Philadelphia, PA USALi, X.论文数: 0 引用数: 0 h-index: 0机构: Univ Hong Kong, Hong Kong, Peoples R China Hosp Univ Penn, Philadelphia, PA USASchuh, A. C.论文数: 0 引用数: 0 h-index: 0机构: Princess Margaret Canc Ctr, Toronto, ON, Canada Hosp Univ Penn, Philadelphia, PA USAChai, X.论文数: 0 引用数: 0 h-index: 0机构: Analysis Grp Inc, Boston, MA USA Hosp Univ Penn, Philadelphia, PA USAXie, J.论文数: 0 引用数: 0 h-index: 0机构: Analysis Grp Inc, Los Angeles, CA USA Hosp Univ Penn, Philadelphia, PA USAYin, L.论文数: 0 引用数: 0 h-index: 0机构: Analysis Grp Inc, Los Angeles, CA USA Hosp Univ Penn, Philadelphia, PA USABui, C. N.论文数: 0 引用数: 0 h-index: 0机构: AbbVie Inc, N Chicago, IL USA Hosp Univ Penn, Philadelphia, PA USA
- [4] Results from a phase I/II trial of cusatuzumab combined with azacitidine in patients with newly diagnosed acute myeloid leukemia who are ineligible for intensive chemotherapyHAEMATOLOGICA, 2023, 108 (07) : 1793 - 1802论文数: 引用数: h-index:机构:Vey, Norbert论文数: 0 引用数: 0 h-index: 0机构: Inst Paoli Calmettes, Hematol Clin, Marseille, France Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandAdes, Lionel论文数: 0 引用数: 0 h-index: 0机构: Hop St Louis, AP HP, Paris, France Univ Paris Cite, Paris, France Ctr Invest Clin INSERM CIC 1427, Paris, France Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandBacher, Ulrike论文数: 0 引用数: 0 h-index: 0机构: Univ Bern, Bern Univ Hosp, Dept Hematol, Inselspital, Bern, Switzerland Univ Bern, Bern Univ Hosp, Cent Hematol Lab, Inselspital, Bern, Switzerland Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandBargetzi, Mario论文数: 0 引用数: 0 h-index: 0机构: Kantonsspital Aarau, Div Hematol & Transfus Med, Aarau, Switzerland Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandFung, Samson论文数: 0 引用数: 0 h-index: 0机构: Fung Consulting Healthcare & Life Sci, Eching, Germany Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandGaidano, Gianluca论文数: 0 引用数: 0 h-index: 0机构: Univ Piemonte Orientale, Dept Translat Med, Div Hematol, Novara, Italy Maggiore Hosp, Novara, Italy Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandGandini, Domenica论文数: 0 引用数: 0 h-index: 0机构: Argenx, Ghent, Belgium Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandHultberg, Anna论文数: 0 引用数: 0 h-index: 0机构: Argenx, Ghent, Belgium Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandJohnson, Amy论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Spring House, PA USA Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandMa, Xuewen论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Spring House, PA USA Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandMuller, Rouven论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Zurich, Dept Med Oncol & Hematol, Zurich, Switzerland Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandNottage, Kerri论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Raritan, NJ USA Univ Hosp, Inselspital, Dept Med Oncol, Bern, Switzerland论文数: 引用数: h-index:机构:Recher, Christian论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Toulouse, Inst Univ Canc Toulouse Oncopole, Serv Hematol, Toulouse, France Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandRiether, Carsten论文数: 0 引用数: 0 h-index: 0机构: Univ Toulouse III Paul Sabatier, Toulouse, France Univ Bern, Bern Univ Hosp, Dept Med Oncol, Inselspital, Bern, Switzerland Univ Bern, Dept Biomed Res DBMR, Bern, Switzerland Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandShah, Priya论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, High Wycombe, Bucks, England Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandTryon, Jeffrey论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Raritan, NJ USA Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandXiu, Liang论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Raritan, NJ USA Univ Hosp, Inselspital, Dept Med Oncol, Bern, SwitzerlandOchsenbein, Adrian F.论文数: 0 引用数: 0 h-index: 0机构: Univ Bern, Bern Univ Hosp, Dept Med Oncol, Inselspital, Bern, Switzerland Univ Bern, Dept Biomed Res DBMR, Bern, Switzerland Univ Hosp, Inselspital, Dept Med Oncol, Bern, Switzerland
- [5] Venetoclax Combined with Homoharringtonine and Cytarabine (HAV) As Induction Treatment in Elder or Intensive Chemotherapy (IC) Ineligible Patients with Newly Diagnosed Acute Myeloid LeukemiaBLOOD, 2023, 142Liu, Kaiqi论文数: 0 引用数: 0 h-index: 0机构: Tianjin Inst Hlth Sci, Tianjin, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis,State Key Lab Expt He, Inst Hematol Blood Dis Hosp,Haihe Lab Cell Ecosys, Tianjin, Peoples R China Tianjin Inst Hlth Sci, Tianjin, Peoples R ChinaSuo, Xiaohui论文数: 0 引用数: 0 h-index: 0机构: Handan Cent Hosp, Dept Hematol, Handan 056000, Hebei, Peoples R China Tianjin Inst Hlth Sci, Tianjin, Peoples R ChinaBai, Guanchen论文数: 0 引用数: 0 h-index: 0机构: Qingdao Univ, Dept Hematol, Affiliated Taian City Cent Hosp, Tai An, Shandong, Peoples R China Tianjin Inst Hlth Sci, Tianjin, Peoples R ChinaYan, Zhangsong论文数: 0 引用数: 0 h-index: 0机构: Tianjin Inst Hlth Sci, Tianjin, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis,State Key Lab Expt He, Inst Hematol Blood Dis Hosp,Haihe Lab Cell Ecosys, Tianjin, Peoples R China Tianjin Inst Hlth Sci, Tianjin, Peoples R ChinaLi, Yang论文数: 0 引用数: 0 h-index: 0机构: Tianjin Inst Hlth Sci, Tianjin, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis,State Key Lab Expt He, Inst Hematol Blood Dis Hosp,Haihe Lab Cell Ecosys, Tianjin, Peoples R China Tianjin Inst Hlth Sci, Tianjin, Peoples R ChinaZhang, Bin论文数: 0 引用数: 0 h-index: 0机构: Tianjin Inst Hlth Sci, Tianjin, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis,State Key Lab Expt He, Inst Hematol Blood Dis Hosp,Haihe Lab Cell Ecosys, Tianjin, Peoples R China Tianjin Inst Hlth Sci, Tianjin, Peoples R ChinaHe, Jinsong论文数: 0 引用数: 0 h-index: 0机构: Tianjin Inst Hlth Sci, Tianjin, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis,State Key Lab Expt He, Inst Hematol Blood Dis Hosp,Haihe Lab Cell Ecosys, Tianjin, Peoples R China Tianjin Inst Hlth Sci, Tianjin, Peoples R ChinaWei, Shuning论文数: 0 引用数: 0 h-index: 0机构: Tianjin Inst Hlth Sci, Tianjin, Peoples R ChinaLi, Qiuling论文数: 0 引用数: 0 h-index: 0机构: Tianjin Inst Hlth Sci, Tianjin, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis,State Key Lab Expt He, Inst Hematol Blood Dis Hosp,Haihe Lab Cell Ecosys, Tianjin, Peoples R China Tianjin Inst Hlth Sci, Tianjin, Peoples R ChinaHu, Bo论文数: 0 引用数: 0 h-index: 0机构: Tianjin Inst Hlth Sci, Tianjin, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis,State Key Lab Expt He, Inst Hematol Blood Dis Hosp,Haihe Lab Cell Ecosys, Tianjin, Peoples R China Tianjin Inst Hlth Sci, Tianjin, Peoples R ChinaMi, Yingchang论文数: 0 引用数: 0 h-index: 0机构: Tianjin Inst Hlth Sci, Tianjin, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol & Blood Dis Hosp, Natl Clin Res Ctr Blood Dis,State Key Lab Expt He, Inst Hematol Blood Dis Hosp,Haihe Lab Cell Ecosys, Tianjin, Peoples R China Tianjin Inst Hlth Sci, Tianjin, Peoples R China
- [6] Decitabine Versus Intensive Chemotherapy for Elderly Patients With Newly Diagnosed Acute Myeloid LeukemiaCLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (05): : 290 - +Choi, Eun-Ji论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South KoreaLee, Je-Hwan论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South KoreaPark, Han-Seung论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South KoreaLee, Jung-Hee论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South KoreaSeol, Miee论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South KoreaLee, Young-Shin论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South KoreaKang, Young-Ah论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea论文数: 引用数: h-index:机构:Woo, Ji Min论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South KoreaLee, Kyoo-Hyung论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, 88,Olymp Ro 43 Gil, Seoul 05505, South Korea
- [7] Decitabine Versus Intensive Chemotherapy for Elderly Patients with Newly Diagnosed Acute Myeloid LeukemiaBLOOD, 2018, 132Choi, Eun-Ji论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South KoreaLee, Je-Hwan论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South KoreaPark, Han-Seung论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South KoreaLee, Jung-Hee论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South KoreaSeol, Miee论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South KoreaLee, Young-Shin论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South KoreaKang, Young-Ah论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South Korea论文数: 引用数: h-index:机构:Woo, Ji Min论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South KoreaLee, Kyoo Hyung论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South Korea Univ Ulsan, Coll Med, Asan Med Ctr, Dept Hematol, Seoul, South Korea
- [8] Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practiceAMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (07) : 790 - 795Apel, Arie论文数: 0 引用数: 0 h-index: 0机构: Shamir Med Ctr, Dept Hematol, Zerifin, Israel Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel Shamir Med Ctr, Dept Hematol, Zerifin, IsraelMoshe, Yakir论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Sourasky Med Ctr, Dept Hematol & Bone Marrow Transplantat, Tel Aviv, Israel Shamir Med Ctr, Dept Hematol, Zerifin, IsraelOfran, Yishai论文数: 0 引用数: 0 h-index: 0机构: Rambam Hlth Care Campus, Dept Hematol & Bone Marrow Transplantat, Haifa, Israel Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel Shamir Med Ctr, Dept Hematol, Zerifin, IsraelGural, Alexander论文数: 0 引用数: 0 h-index: 0机构: Hasassah Hebrew Univ Med Ctr, Dept Hematol, Leukemia Serv, Jerusalem, Israel Shamir Med Ctr, Dept Hematol, Zerifin, IsraelWolach, Ofir论文数: 0 引用数: 0 h-index: 0机构: Belinson Hosp, Inst Hematol, Davidoff Canc Ctr, Rabin Med Ctr, Petah Tiqwa, Israel Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel Shamir Med Ctr, Dept Hematol, Zerifin, IsraelGanzel, Chezi论文数: 0 引用数: 0 h-index: 0机构: Shaare Zedek Med Ctr, Dept Hematol, Jerusalem, Israel Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel Shamir Med Ctr, Dept Hematol, Zerifin, IsraelCanaani, Jonathan论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Univ, Chaim Sheba Med Ctr, Div Hematol, Tel Aviv, Israel Shamir Med Ctr, Dept Hematol, Zerifin, IsraelZektser, Miri论文数: 0 引用数: 0 h-index: 0机构: Soroka Univ Med Ctr, Inst Hematol, Fac Hlth Sci, Beer Sheva, Israel Shamir Med Ctr, Dept Hematol, Zerifin, IsraelDuek, Adrian论文数: 0 引用数: 0 h-index: 0机构: Assuta Med Ctr, Dept Hematol, Ashdod, Israel Shamir Med Ctr, Dept Hematol, Zerifin, IsraelStemer, Galia论文数: 0 引用数: 0 h-index: 0机构: Haemek Med Ctr, Hematol Unit, Afula, Israel Shamir Med Ctr, Dept Hematol, Zerifin, IsraelHellman, Ilana论文数: 0 引用数: 0 h-index: 0机构: Meir Med Ctr, Hematol Unit, Kefar Sava, Israel Shamir Med Ctr, Dept Hematol, Zerifin, IsraelBasood, May论文数: 0 引用数: 0 h-index: 0机构: Tel Aviv Sourasky Med Ctr, Dept Hematol & Bone Marrow Transplantat, Tel Aviv, Israel Shamir Med Ctr, Dept Hematol, Zerifin, IsraelFrisch, Avraham论文数: 0 引用数: 0 h-index: 0机构: Rambam Hlth Care Campus, Dept Hematol & Bone Marrow Transplantat, Haifa, Israel Shamir Med Ctr, Dept Hematol, Zerifin, IsraelLeibovitch, Chiya论文数: 0 引用数: 0 h-index: 0机构: Belinson Hosp, Inst Hematol, Davidoff Canc Ctr, Rabin Med Ctr, Petah Tiqwa, Israel Shamir Med Ctr, Dept Hematol, Zerifin, IsraelKoren-Michowitz, Maya论文数: 0 引用数: 0 h-index: 0机构: Shamir Med Ctr, Dept Hematol, Zerifin, Israel Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel Shamir Med Ctr, Dept Hematol, Zerifin, Israel
- [9] Patient and Physician Preferences for Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) in Patients Not Candidates for Intensive ChemotherapyBLOOD, 2021, 138Zhou, Mo论文数: 0 引用数: 0 h-index: 0机构: Anal Grp, Boston, MA USA Anal Grp, Boston, MA USAYang, Hongbo论文数: 0 引用数: 0 h-index: 0机构: Anal Grp, Boston, MA USA Anal Grp, Boston, MA USASong, Yan论文数: 0 引用数: 0 h-index: 0机构: Anal Grp, Boston, MA USA Anal Grp, Boston, MA USAMarshall, Deborah A.论文数: 0 引用数: 0 h-index: 0机构: Univ Calgary, Cumming Sch Med, Calgary, AB, Canada Anal Grp, Boston, MA USAGriffin, James D.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA USA Anal Grp, Boston, MA USASaini, Lalit论文数: 0 引用数: 0 h-index: 0机构: London Hlth Sci Ctr, London, ON, Canada Anal Grp, Boston, MA USAShah, Manasee V.论文数: 0 引用数: 0 h-index: 0机构: Astellas Pharma Inc, Northbrook, IL USA Anal Grp, Boston, MA USA
- [10] Risk Stratification of Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia Unfit for Intensive ChemotherapyBLOOD, 2021, 138Gardeney, Helene论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceDiaz, Jose Miguel Torregrosa论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceBasle, Caroline论文数: 0 引用数: 0 h-index: 0机构: CHU Miletrie, Serv Hematol Biol, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceCayssials, Emilie论文数: 0 引用数: 0 h-index: 0机构: Univ Poitiers Hosp, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceBouyer, Sabrina论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Serv Hematol Biol, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceMoya, Niels论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceGruchet, Cecile论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceSabirou, Florence论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceBobin, Arthur论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceLevy, Anthony论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceNsiala, Laly论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceCailly, Laura论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceVonfeld, Mathilde论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceDesmier, Deborah论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceLeleu, Xavier论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Oncol Hematol & Therapie Cellulaire, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, FranceHernanz, Maria Pilar Gallego论文数: 0 引用数: 0 h-index: 0机构: CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, France CHU Poitiers, Serv Hematol & Therapie Cellulaire, Poitiers, France